2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …
JA Joglar, MK Chung, AL Armbruster, EJ Benjamin… - Circulation, 2024 - Am Heart Assoc
AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …
Reversal and resumption of anticoagulants in patients with anticoagulant-associated intracerebral hemorrhage
J Yang, J Jing, S Chen, X Liu, J Wang, C Pan… - European Journal of …, 2024 - Springer
The use of anticoagulants has become more frequent due to the progressive aging
population and increased thromboembolic events. Consequently, the proportion of …
population and increased thromboembolic events. Consequently, the proportion of …
[HTML][HTML] Effectiveness and safety of non-vitamin K oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke: A systematic review and …
Introduction: Current evidence regarding the clinical outcomes of non-vitamin K oral
anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation (AF) and previous …
anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation (AF) and previous …
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart …
WC Members, JA Joglar, MK Chung… - Journal of the American …, 2024 - Elsevier
Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …
Epicardial left atrial appendage clipping versus direct oral anticoagulant to reduce stroke risk in non-paroxysmal atrial fibrillation (LAA-CLIP): rationale, design and …
C Yu, H Li, C Lei, Y Wang, S Chen, Y Zhao, Z Zheng - BMJ open, 2024 - bmjopen.bmj.com
Introduction The prevalence of atrial fibrillation (AF) is increasing globally, and stroke
prevention is the key to reduce the morbidity and mortality related to AF. Currently, direct oral …
prevention is the key to reduce the morbidity and mortality related to AF. Currently, direct oral …
Left atrial appendage occlusion in patients with spontaneous intracerebral hemorrhage: An observational study
C Moliner-Abos, B Alberti-Vall, X Millan-Alvarez… - Journal of Stroke and …, 2024 - Elsevier
Background Patients with atrial fibrillation (AF) and intracerebral hemorrhage (ICH) are at
high risk of ischemic and recurrent bleeding events. Therefore, the decision of restarting or …
high risk of ischemic and recurrent bleeding events. Therefore, the decision of restarting or …
[HTML][HTML] Protocol: Epicardial left atrial appendage clipping versus direct oral anticoagulant to reduce stroke risk in non-paroxysmal atrial fibrillation (LAA-CLIP) …
C Yu, H Li, C Lei, Y Wang, S Chen, Y Zhao, Z Zheng - BMJ Open, 2024 - ncbi.nlm.nih.gov
Introduction The prevalence of atrial fibrillation (AF) is increasing globally, and stroke
prevention is the key to reduce the morbidity and mortality related to AF. Currently, direct oral …
prevention is the key to reduce the morbidity and mortality related to AF. Currently, direct oral …
Exploring the potential mechanism and molecular targets of Taohong Siwu Decoction against deep vein thrombosis based on network pharmacology and analysis …
W Fan, J Liu, Q Liu - Medicine, 2024 - journals.lww.com
This study aims to investigate the mechanism of Taohong Siwu Decoction (THSWD) against
deep vein thrombosis (DVT) using network pharmacology and molecular docking …
deep vein thrombosis (DVT) using network pharmacology and molecular docking …
[HTML][HTML] Recognize, reverse, resume, reduce: A framework for managing severe DOAC-related bleeding
S Cormier, DM Siegal - Thrombosis Update, 2024 - Elsevier
Bleeding is the main complication of treatment with anticoagulants, the most common
adverse drug event that leads to emergency department visits, hospital admission, and …
adverse drug event that leads to emergency department visits, hospital admission, and …
Cerebral haemorrhage in the patient with atrial fibrillation: do we employ the direct oral anticoagulants without waiting too long?
G Vassiliki'Coutsoumbas… - European Heart Journal …, 2024 - academic.oup.com
Intracranial haemorrhage (ICH) is the most feared haemorrhagic complication of oral
anticoagulant therapy (OAT), although the risk is significantly lower with direct oral …
anticoagulant therapy (OAT), although the risk is significantly lower with direct oral …